Form D · Biotechnology
Bergen Medical Products, Inc.
Cedar Knolls, NJ · CIK 0001615712
Offering snapshot reported Dec 2, 2016 · SEC filing
- Reported sold
- $898K Offering amount: $3.03M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Nov 7, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 2, 2016 | Initial | $898,389 | No comparison | 19 | SEC filing |
| Jun 16, 2016 | Amendment | $673,354 | $173,354vs Apr 26, 2016 | 19 | SEC filing |
| Apr 26, 2016 | Initial | $500,000 | No comparison | 17 | SEC filing |
| Oct 15, 2014 | Amendment | $1,699,935 | $65,000vs Aug 4, 2014 | 21 | SEC filing |
| Aug 4, 2014 | Initial | $1,634,935 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-275547
Source: Form D, filed Dec 2, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bailye | Director |
| Robert Laudadio | Director, Executive |
| Kathryn Swintek | Director |
| Melissa Vinci Rainis | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
16 Wing Drive
Cedar Knolls, NJ, 07927
Cedar Knolls, NJ, 07927